Article 08 Oct 2026 USPTO Institutes Four IPRs Challenging Janssen’s Golimumab Method-of-Treatment Patents United States IP
Article 24 Apr 2026 Federal Circuit Reverses JMOL And Reinstates Jury Verdict In Teva v. Lilly United States IP
Article 27 Aug 2025 Accord BioPharma Announces Commercial Launch Of IMULDOSA® (ustekinumab-srlf) Prefilled Syringes In The United States United States Healthcare
Article 25 Jun 2025 Recent PTAB Developments For Regeneron's Aflibercept Formulation Patent United States IP
Article 11 Jun 2024 Updates On Aflibercept Biosimilar Approvals And BPCIA Litigation United States IP
Article 26 Apr 2024 DOJ Files False Claims Act Complaint Against Regeneron, Alleging Fraudulent Eylea Drug Pricing United States Healthcare
Article 11 Mar 2024 Post-Trial Updates On Regeneron V. Mylan (Aflibercept) BPCIA Litigation United States IP
Article 02 Sep 2022 Amgen Announces Positive Top-Line Results From Phase 3 Study Of Eculizumab Biosimilar United States Healthcare